Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04514770
Other study ID # 11/2019 OBSGN 27
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 3, 2019
Est. completion date March 20, 2020

Study information

Verified date August 2020
Source Menoufia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigation the effect of timing of amniotomy (early versus delayed) after vaginal misoprostol in induced labor.

Condition: induction of labour intervention: eary versus late amniotomy on labour induction after vaginal misoprostol Phase: Not applicable


Description:

study type: randomized clinical trial actual enrollment: 140 allocation: Random intervention model: two groups assignment masking: open lebal primary purpose: induction of labour actual study start: May 3, 2019 Primary Completion: January 10, 2020 actual study completion date: March 20, 2020


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date March 20, 2020
Est. primary completion date January 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

1. Pregnant women at 36 weeks gestation or more

2. Nullipara

3. singleton fetus

4. cephalic presentation with common medical causes for labour induction e.g. intrauterine fetal growth restriction, post term pregnancy and preeclampsia.

Exclusion Criteria:

1. Macrocosmic babies with estimated fetal weight of more than 4000 gram

2. Previous uterine scars

3. Pre labor premature rupture of fetal membranes

4. Polyhydramnios.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Misoprostol
rupture of membrane early and late

Locations

Country Name City State
Egypt Menoufia University hospital Shibin Al Kawm Menoufia

Sponsors (1)

Lead Sponsor Collaborator
Menoufia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary successful induction definition of successful induction is occurrence of vaginal delivery within 24 hours from the beginning of induction immediately after intervention
Primary induction-delivery interval duration of labor and amniotomy delivery interval immediately after intervention
Secondary misoprostol doses administered number of misoprostol doses administered during the intervention
Secondary the need for augmentation of labor the need for augmentation of labor by oxytocin and perinatal outcomes included cord prolapse and abnormal FHR changes during labor during the intervention
Secondary intrapartum meconium intrapartum meconium passage during the intervention
Secondary Apgar score Apgar score less than 7 at 1 and 5 minutes during the intervention
Secondary newborn admission in the neonatal intensive care unit newborn admission in the neonatal intensive care unit (NICU). immediately after intervention
See also
  Status Clinical Trial Phase
Completed NCT02539199 - Vaginally Administered Versus Per Oral Misoprostol in Induction of Labour Phase 4
Completed NCT03016208 - The Misoprostol Vaginal Insert for Labour Induction N/A
Recruiting NCT02168881 - Oral Misoprostol Versus Vaginal Dinoprostone For Induction Of Labour: A Randomized Controlled Clinical Trial N/A
Completed NCT02904317 - Misoprostol for Labour Induction N/A